Correlation Between Revelation Biosciences and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and Eliem Therapeutics, you can compare the effects of market volatilities on Revelation Biosciences and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Eliem Therapeutics.
Diversification Opportunities for Revelation Biosciences and Eliem Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Revelation and Eliem is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Revelation Biosciences and Eliem Therapeutics
Given the investment horizon of 90 days Revelation Biosciences is expected to under-perform the Eliem Therapeutics. In addition to that, Revelation Biosciences is 1.44 times more volatile than Eliem Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Eliem Therapeutics is currently generating about 0.04 per unit of volatility. If you would invest 256.00 in Eliem Therapeutics on August 26, 2024 and sell it today you would earn a total of 44.00 from holding Eliem Therapeutics or generate 17.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.6% |
| Values | Daily Returns |
Revelation Biosciences vs. Eliem Therapeutics
Performance |
| Timeline |
| Revelation Biosciences |
| Eliem Therapeutics |
Revelation Biosciences and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revelation Biosciences and Eliem Therapeutics
The main advantage of trading using opposite Revelation Biosciences and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Revelation Biosciences vs. Eliem Therapeutics | Revelation Biosciences vs. HCW Biologics | Revelation Biosciences vs. Scpharmaceuticals | Revelation Biosciences vs. Milestone Pharmaceuticals |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |